Alzamend Neuro, Inc. (ALZN) KPIs and segments
ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
$1.13−0.05 (-4.24%)
Close on Nov 17, 2026Market cap $5.45MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Alzamend Neuro's business
Coming soon
This tab will track the numbers specific to Alzamend Neuro's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?